tiprankstipranks
Standard Biotools Inc (CH:FLB)
NASDAQ:FLB
Switzerland Market
FLB
Standard BioTools
RESEARCH TOOLSreports

Standard BioTools (FLB) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Jul 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.01
Last Year’s EPS
-0.04
Same Quarter Last Year
Analyst Consensus
Hold
Based on 1 Analysts Ratings

Earnings Call Summary

Q1 2025
Earnings Call Date:May 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflected a well-managed quarter with robust strategic initiatives and strong cost management, despite facing significant revenue declines and challenges in the U.S. academic market. The company's strong cash position and strategic product expansions provide a positive outlook, though the impact of tariffs and revenue declines remain concerns.
Company Guidance
During the Standard BioTools first quarter 2025 earnings call, the company reiterated its full-year revenue guidance of $165 million to $175 million, despite a 10% year-over-year decline in Q1 revenue to $40.8 million. The decline was primarily due to lower consumables and services revenue, with consumables down 16% and services down 16% year-over-year. Instrument sales, however, grew by 24%, driven by the Hyperion XTi system. The company reported non-GAAP gross margins of 53.2%, impacted by lower volumes and product mix, and a non-GAAP operating loss improvement of 45% year-over-year. Adjusted EBITDA loss improved 29% to $16.9 million, and cash burn was reduced by 33%. The company emphasized its strategic focus on proteomics and highlighted new product launches, including the CyTOF-XT Pro and SomaScan Select Asset, as key drivers for future growth.
Strategic Product Launches and Expansions
Standard BioTools announced a new SomaScan offering and expanded its reach with the NGS-based Illumina partner solution, enhancing translational and clinical research capabilities.
Strength in Instrument Sales
Instruments saw a double-digit year-over-year growth, driven by demand for Hyperion XTi spatial imaging systems.
Cost Management and Operational Improvements
Non-GAAP operating expenses decreased by 22% year-over-year, operating loss improved by 45%, and adjusted EBITDA improved by 29%.
Healthy Cash Position
Standard BioTools ended the quarter with $261 million in cash and no material debt, emphasizing a strong balance sheet.
Positive Traction with Pharma and International Markets
Biopharma engagement and international markets remained resilient, contributing positively to overall performance.

Standard BioTools (CH:FLB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
Daily Earnings Calendar >

CH:FLB Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
-0.01 / -
-0.04―――
May 05, 2026
2026 (Q1)
-0.04 / -0.03
-0.05642.86% (+0.02)――
Feb 24, 2026
2025 (Q4)
-0.04 / 0.03
-0.072144.44% (+0.10)――
Nov 04, 2025
2025 (Q3)
-0.03 / -0.07
-0.056-28.57% (-0.02)――
Aug 11, 2025
2025 (Q2)
-0.05 / -0.04
-0.09658.33% (+0.06)――
May 06, 2025
2025 (Q1)
-0.04 / -0.06
-0.21574.07% (+0.16)
Feb 26, 2025
2024 (Q4)
-0.05 / -0.07
-0.19964.00% (+0.13)
Oct 30, 2024
2024 (Q3)
-0.07 / -0.06
-0.21574.07% (+0.16)
Jul 31, 2024
2024 (Q2)
-0.07 / -0.10
-0.17545.45% (+0.08)
May 08, 2024
2024 (Q1)
-0.09 / -0.22
-0.167-28.57% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does Standard Biotools Inc (CH:FLB) report earnings?
Standard Biotools Inc (CH:FLB) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
    What is Standard Biotools Inc (CH:FLB) earnings time?
    Standard Biotools Inc (CH:FLB) earnings time is at Jul 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Standard Biotools Inc stock?
          The P/E ratio of Standard BioTools is N/A.
            What is CH:FLB EPS forecast?
            CH:FLB EPS forecast for the fiscal quarter 2026 (Q2) is -0.01.